Literature DB >> 3441293

Oral administration of nimodipine accelerates functional recovery following peripheral nerve damage in the rat.

C E van der Zee1, T Schuurman, J Traber, W H Gispen.   

Abstract

Oral administration of the Ca2+-entry blocker nimodipine accelerates in a dose-dependent manner the recovery of sensorimotor function following a crush lesion of the rat sciatic nerve. The beneficial effect of nimodipine was apparent in both a foot shock withdrawal test and in a test analyzing the walking pattern of the rat. These data are the first demonstration of nimodipine-induced enhanced recovery following peripheral nerve damage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3441293     DOI: 10.1016/0304-3940(87)90231-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Recovery of laryngeal function after intraoperative injury to the recurrent laryngeal nerve.

Authors:  Per Mattsson; Jonas Hydman; Mikael Svensson
Journal:  Gland Surg       Date:  2015-02

2.  Nerve injury induced by vibration: prevention of the effect of a conditioning lesion by D600, a Ca2+ channel blocker.

Authors:  A Widerberg; S Bergman; N Danielsen; G Lundborg; L B Dahlin
Journal:  Occup Environ Med       Date:  1997-05       Impact factor: 4.402

3.  Putative neurotrophic factors and functional recovery from peripheral nerve damage in the rat.

Authors:  C E Van der Zee; J H Brakkee; W H Gispen
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

4.  Effect of piracetam and nimodipine on full-thickness skin burns in rabbits.

Authors:  Elif Sari; Gungor C Dincel
Journal:  Int Wound J       Date:  2015-07-20       Impact factor: 3.315

5.  Nimodipine and acceleration of functional recovery of the facial nerve after crush injury.

Authors:  Robin W Lindsay; James T Heaton; Colin Edwards; Christopher Smitson; Tessa A Hadlock
Journal:  Arch Facial Plast Surg       Date:  2010 Jan-Feb

6.  Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.

Authors:  A C Kappelle; B Bravenboer; T van Buren; J Traber; D W Erkelens; W H Gispen
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

7.  Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.

Authors:  A C Kappelle; G Biessels; B Bravenboer; T van Buren; J Traber; D J de Wildt; W H Gispen
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

8.  Evaluating Gait and Locomotion in Rodents with the CatWalk.

Authors:  Jacqueline M Garrick; Lucio G Costa; Toby B Cole; Judit Marsillach
Journal:  Curr Protoc       Date:  2021-08

Review 9.  Review of Drug Therapy for Peripheral Facial Nerve Regeneration That Can Be Used in Actual Clinical Practice.

Authors:  Soo Young Choi; Jung Min Kim; Junyang Jung; Dong Choon Park; Myung Chul Yoo; Sung Soo Kim; Sang Hoon Kim; Seung Geun Yeo
Journal:  Biomedicines       Date:  2022-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.